Vladimir L. Sukhorukov
Wuerzburg, BY 97074, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Correction: Brosch et al. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration. Cancers 2022, 14, 5794.
Journal: Cancers
Published: September 27, 2023
Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration.
Journal: Cancers
Published: October 06, 2022
Contraction of the rigor actomyosin complex drives bulk hemoglobin expulsion from hemolyzing erythrocytes.
Journal: Biomechanics and modeling in mechanobiology
Published: May 11, 2022
Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs.
Journal: BMC cancer
Published: November 02, 2020
A role for TASK2 channels in the human immunological synapse.
Journal: European journal of immunology
Published: June 07, 2019
MEK-inhibitor PD184352 enhances the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922: the role of cell type and drug-irradiation schedule.
Journal: Oncotarget
Published: August 09, 2018
Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.
Journal: Oncotarget
Published: January 12, 2017
Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells: The role of drug-irradiation schedule.
Journal: Oncotarget
Published: September 24, 2015
Electro-microinjection of fish eggs with an immobile capillary electrode.
Journal: Biomicrofluidics
Published: September 10, 2015
Hypotonic activation of the myo-inositol transporter SLC5A3 in HEK293 cells probed by cell volumetry, confocal and super-resolution microscopy.
Journal: PloS one
Published: June 26, 2014
Last Updated: 09/26/2026